. Author manuscript; available in PMC: 2016 Apr 1.

Published in final edited form as: Am J Ophthalmol. 2015 Jan 15;159(4):707–713.e2. doi: 10.1016/j.ajo.2015.01.009

Table 2.

Association between Statin Use and Uveitis: Clinical Characteristics of Incident Uveitis Cases and Controls

	Incident Cases	General Controls	p-value^a	Ophthalmology Controls	p-value^a
Total	108	540		540

Medications
Statins	21 (19%)	160 (30%)	0.03	204 (38%)	<0.001
High Dose Statins	2 (2%)	17 (3%)	0.75	14 (3%)	1.00
Other Lipid Lowering Agents	4 (4%)	25 (5%)	0.80	17 (3%)	0.77

Chronic Conditions
Lipid Metabolism Disorder	44 (41%)	231 (43%)	0.75	295 (55%)	0.01
Diabetes	15 (14%)	118 (22%)	0.07	139 (26%)	0.01
Hypertension	36 (33%)	224 (41%)	0.13	280 (52%)	<0.001
Autoimmune Diseases^b	8 (7%)	17 (3%)	0.051	20 (4%)	0.11

P-values obtained by Fisher’s exact test

Includes reactive arthritis, sarcoidosis, Behcet’s disease, multiple sclerosis, polyarteritis nodosa, granulomatosis with polyangiitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, inflammatory bowel disease, juvenile idiopathic arthritis, and systemic lupus erythematosus